May 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shake Shack, Inc. (“Shake Shack” or “the Company”) (NYSE: SHAK). Investors who purchased Shake Shack securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Shake… read more
May 11, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gaia, Inc. (“Gaia” or “the Company”) (NASDAQ: GAIA). Investors who purchased Gaia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gaia has violated federal… read more
May 11, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stryker Corporation (“Stryker” or “the Company”) (NYSE: SYK). Investors who purchased Stryker securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Stryker has violated federal… read more
May 8, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ: SMTI). Investors who purchased Sanara securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sanara has violated… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Norwegian Cruise Line Holdings Ltd. (“Norwegian” or “the Company”) (NYSE: NCLH). Investors who purchased Norwegian securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Norwegian… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Clorox Company (“Clorox” or “the Company”) (NYSE: CLX). Investors who purchased Clorox securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Clorox has violated… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cogent Communications Holdings, Inc. (“Cogent” or “the Company”) (NASDAQ: CCOI). Investors who purchased Cogent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cogent has… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ryan Specialty Holdings, Inc. (“Ryan” or “the Company”) (NYSE: RYAN). Investors who purchased Ryan securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ryan has… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Marzetti Company (“Marzetti” or “the Company”) (NASDAQ: MZTI). Investors who purchased Marzetti securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Marzetti has violated… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Primoris Services Corporation (“Primoris” or “the Company”) (NYSE: PRIM). Investors who purchased Primoris securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Primoris has violated… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Merchants Bancorp (“Merchants Bancorp” or “the Company”) (NASDAQ: MBIN). Investors who purchased Merchants Bancorp securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Merchants Bancorp… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Option Care Health, Inc. (“Option Care” or “the Company”) (NASDAQ: OPCH). Investors who purchased Option Care securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Qiagen N.V. (“Qiagen” or “the Company”) (NYSE: QGEN). Investors who purchased Qiagen securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Qiagen has violated federal… read more
May 7, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meridian Corporation (“Meridian” or “the Company”) (NASDAQ: MRBK). Investors who purchased Meridian securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Meridian has violated federal… read more
May 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Willis Towers Watson plc (“Willis Towers Watson” or “the Company”) (NASDAQ: WTW). Investors who purchased Willis Towers Watson securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
May 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hycroft Mining Holding Corporation (“Hycroft Mining” or “the Company”) (NASDAQ: HYMC). Investors who purchased Hycroft Mining securities prior to June 1, 2025, and continue to hold to the present, are encouraged… read more
May 5, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Blaize Holdings, Inc. (“Blaize” or “the Company”) (NASDAQ: BZAI). Investors who purchased Blaize securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Blaize has violated… read more
May 5, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Roblox Corporation (“Roblox” or “the Company”) (NYSE: RBLX). Investors who purchased Roblox securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Roblox has violated federal… read more
May 5, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Erasca, Inc. (“Erasca” or “the Company”) (NASDAQ: ERAS). Investors who purchased Erasca securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Erasca has violated federal… read more
May 5, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GE HealthCare Technologies Inc. (“GE HealthCare” or “the Company”) (NASDAQ: GEHC). Investors who purchased GE HealthCare securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
May 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating whether Lee Enterprises’s board of directors breached its fiduciary duties. Investors who purchased Lee Enterprises and continue to hold to the present are encouraged to obtain additional information and assist the investigation. Lee Enterprises Investigation Details The investigation… read more
May 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Check Point Software Technologies Ltd. (“Check Point” or “the Company”) (NASDAQ: CHKP). Investors who purchased Check Point securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
April 30, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. (“Humana” or “the Company”) (NYSE: HUM). Investors who purchased Humana securities prior to June 27, 2022, and continue to hold to the present, are encouraged to obtain additional information… read more
April 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA) and Ligand Pharmaceuticals Inc (“Ligand”) (NASDAQ: LGND). Investors who purchased XOMA and continue to hold to the present are encouraged to obtain additional information and assist the investigation. XOMA… read more
April 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Compass Therapeutics, Inc. (“Compass” or “the Company”) (NASDAQ: CMPX). Investors who purchased Compass securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Compass has violated… read more
April 29, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spotify Technology S.A. (“Spotify” or “the Company”) (NYSE: SPOT). Investors who purchased Spotify securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Spotify has violated… read more
April 28, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between RE/MAX Holdings, Inc. (“RE/MAX”) (NYSE: RMAX) and The Real Brokerage Inc. (“The Real Brokerage”) (NASDAQ: REAX). Investors who purchased RE/MAX and continue to hold to the present are encouraged to obtain additional information and assist… read more
April 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Franklin BSP Realty Trust, Inc. (“FBRT” or “the Company”) (NYSE: FBRT). Investors who purchased FBRT securities prior to November 5, 2024, and continue to hold to the present, are encouraged to… read more
April 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Navan, Inc. (“Navan” or “the Company”) (NASDAQ: NAVN). Investors who purchased Navan securities prior to October 31, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
April 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nano-X Imaging Ltd. (“Nano-X” or “the Company”) (NASDAQ: NNOX). Investors who purchased Nano-X securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nano-X has violated… read more